RE:RE:RE:RE:RE:No volume and no liquiditySure.. Odds are better for Spectral in round 2.. Because of Dialco, sum of the parts is a lot higher then the current market cap.. No longer a 1 tricke poney and I give full marks to the management for reducing the risk...
With Phase III trial, once again because it is an open trial and FDA has given them all types of breaks to make it a success so hopefully, there won't a misstep like the last time, few years back when share price touched $ 1.75 + and a week after Dr. Walker's very bullish presentation, it was a fiasco when share price collapsed under 0.20
Having gone through 3-4 Phase III trials in biotechs and seeming a sure thing goes bad is an experience every share holder go through investing in biotechs hence my comment about a spinning roulette..
But because of Disalco + PMS and current valuation, my other comment about the potential payout of whether we just get our money back and a lot of hard earned 'experience' or A real multibagger.. Jury is obviously out on that..
Having said that, as a Disclaimer, I do own 2xx,xxx + shares so I am not going any where until the wheel stop or we are clear about the winning Number.. I also have couple of friends, physicians in fact who on my say so has actually a mulitple of my positions so in practical terms, a lot is riding on the results even for so called small retail players..
FWIW